BEVERLY HILLS, Calif., Feb. 12, 2015 (GLOBE NEWSWIRE) -- mCig® Inc. (OTCBB: MCIG), a cannabis-related holdings and incubation company, announces the launch of its general construction and engineering design division, highlighted by the signing of a partnership agreement with ClimaGrow by Elkins. The new division will service all legal recreational and medical cannabis states, and will focus specifically on the construction of growing and processing facilities, extraction and refinement centers, and retail distribution outlets.
mCig, Inc. together with ClimaGrow, will offer producers of cannabis the ability to completely control the environment their plants are grown in, resulting in increased productions and safer products for consumers. ClimaGrow by Elkins is a Washington State-based HVAC and climate control design and engineering firm, and is North America's first and leading Cannabis-specific Climate Control Company. Through this partnership, mCig will be offering customers its full range of facility services including temperature management, humidity control, Co2 monitoring & disbursement, air purification, odor containment, disease & pest prevention, and energy-savings solutions.
Seizing upon the cannabis industry's exponential expansion, mCig plans to monetize a growing pipeline of projects across multiple legal states and tribal lands, and anticipates significant revenues potential resulting from this partnership over the next several years and beyond.
"With strong leadership in our new construction division coupled with the expertise provided by ClimaGrow, we are happy to expand into this area of specialty within the cannabis industry. Over the last year, we have seen significant increases of new technology introduced to the cannabis market; among them are lighting, nutrient delivery systems, and HVAC. Together with ClimaGrow, we have the benefit of industry-leading expertise that is leap years ahead of the competition. We are excited to bring this knowledge to wherever the law permits throughout the nation in order to help our customers be successful," said Paul Rosenberg.
"We are thrilled to be in partnership with mCig, Inc., who will be able to expand upon our services nationwide for cannabis producers," said Jesse Elkins, CEO of ClimaGrow. "Having proven ourselves on the front lines in Washington and Oregon as the leading cannabis climate control experts, each state that follows suit and legalizes for recreational production will be able to obtain our services, and with it, all of our knowledge and experience in the industry. mCig and ClimaGrow have a team of experts dedicated to the production of cannabis, and our proven track record in engineering very highly productive grow facilities includes some of the first ever legal cannabis producers in the country," added Mr. Elkins.
About mCig, Inc.
Headquartered in Beverly Hills, CA, mCig, Inc. (MCIG) is a leading manufacturer and marketer of portable and home vaporizers, THC extracts and related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable, vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.